Trials / Unknown
UnknownNCT04221360
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability After Oral Administration of High Dose CKD-375 and D390 in Healthy Adults.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of CKD-375.
Detailed description
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability After Oral Administration of High Dose CKD-375 and D390 in Healthy Adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-375 | Test drug, QD, PO |
| DRUG | D390 | Reference drug, QD, PO |
Timeline
- Start date
- 2020-01-29
- Primary completion
- 2020-03-06
- Completion
- 2020-06-08
- First posted
- 2020-01-09
- Last updated
- 2020-01-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04221360. Inclusion in this directory is not an endorsement.